Through the spring and early summer of 2016, Myra was plagued by headaches. “They were short headaches at first,” Myra said. “But then I started to get really bad migraine-type headaches that affect my vision.” She was in and out of the doctor’s office often, but it was proving difficult to find the root of her pain.
Then, in July, when the pain was nearly unbearable, tests revealed Myra had a rare form of lymphoma called primary CNS ALCL.
Myra’s family turned to St. Jude Children’s Research Hospital, where her treatment included radiation therapy and chemotherapy. She also received physical and occupational therapies and attended the St. Jude school program.
Treatments invented at St. Jude have helped push the overall childhood cancer survival rate from 20% to more than 80% since it opened more than 50 years ago. St. Jude is working to drive the overall survival rate for childhood cancer to 90%, and we won’t stop until no child dies from cancer.
Myra completed treatment in 2017 and now returns to St. Jude for regular checkups. “Everything about St. Jude is incredible,” she said. “I’m thankful for everything they’ve done for me.”
Myra is taking college courses and plans on studying psychology and art therapy, with an eye toward becoming a Child Life specialist.
Join St. Jude in September to help patients, like Myra, during Childhood Cancer Awareness Month. Let’s end childhood cancer. Together.